Temozolomide treatment induces lncRNA MALAT1 in an NF-кB and p53 co-dependent manner in glioblastoma

Alkylating chemotherapy is a central component of the management of glioblastoma (GBM). Among the factors that regulate the response to alkylation damage, NF-кB acts to both promote and block cytotoxicity. In this study, we used genome-wide expression analysis in U87 GBM to identify NF-кB-dependent...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res
Asıl Yazarlar: Voce, David J., Bernal, Giovanna M., Wu, Longtao, Crawley, Clayton D., Zhang, Wei, Mansour, Nassir M., Cahill, Kirk E., Szymura, Szymon J., Uppal, Abhineet, Raleigh, David R., Spretz, Ruben, Nunez, Luis, Larsen, Gustavo, Khodarev, Nikolai N., Weichselbaum, Ralph R., Yamini, Bakhtiar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522287/
https://ncbi.nlm.nih.gov/pubmed/30940658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-2170
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller